Potential short-term use of oral cladribine in treatment of relapsing-remitting multiple sclerosis

Multiple sclerosis (MS) is a chronic, immune-mediated disorder of the central nervous system. The clinical course of MS varies among patients. Currently, interferon (IFN) products, including IFN β-1a administered intramuscularly or subcutaneously and IFN β-1b subcutaneously, glatiramer acetate, nata...

Descripción completa

Detalles Bibliográficos
Autores principales: Murphy, Julie A, Harris, Jacklyn A, Crannage, Andrew J
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951744/
https://www.ncbi.nlm.nih.gov/pubmed/20957121
http://dx.doi.org/10.2147/NDT.S3501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2951744/
https://www.ncbi.nlm.nih.gov/pubmed/20957121
http://dx.doi.org/10.2147/NDT.S3501

Ejemplares similares